Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000322377 | SCV000345813 | uncertain significance | not provided | 2016-09-22 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001079416 | SCV000555840 | likely benign | Bloom syndrome | 2025-01-08 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000566804 | SCV000672930 | likely benign | Hereditary cancer-predisposing syndrome | 2017-06-28 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000322377 | SCV002006795 | likely benign | not provided | 2021-05-03 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV001820844 | SCV002069625 | likely benign | not specified | 2021-07-26 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000566804 | SCV002531827 | likely benign | Hereditary cancer-predisposing syndrome | 2021-01-12 | criteria provided, single submitter | curation | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000322377 | SCV002774104 | likely benign | not provided | 2022-08-22 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000322377 | SCV004130910 | likely benign | not provided | 2022-08-01 | criteria provided, single submitter | clinical testing | BLM: BP4, BP7 |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001820844 | SCV005077337 | likely benign | not specified | 2024-04-07 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001079416 | SCV001454868 | likely benign | Bloom syndrome | 2020-09-16 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003910047 | SCV004718155 | likely benign | BLM-related disorder | 2019-06-19 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |